Grant, A; Neuberger J (1999). "Guidelines on the use of liver biopsy in clinical practice". Gut45 (Suppl 4): 1–11. doi:10.1136/gut.45.2008.iv1. பப்மெட்:10485854. http://gut.bmj.com/cgi/content/full/45/suppl_4/IV1. "The main cause of mortality after percutaneous liver biopsy is intraperitoneal haemorrhage as shown in a retrospective Italian study of 68,000 percutaneous liver biopsies in which all six patients who died did so from intraperitoneal haemorrhage. Three of these patients had had a laparotomy, and all had either cirrhosis or malignant disease, both of which are risk factors for bleeding.".
Grant, A; Neuberger J (1999). "Guidelines on the use of liver biopsy in clinical practice". Gut45 (Suppl 4): 1–11. doi:10.1136/gut.45.2008.iv1. பப்மெட்:10485854. http://gut.bmj.com/cgi/content/full/45/suppl_4/IV1. "The main cause of mortality after percutaneous liver biopsy is intraperitoneal haemorrhage as shown in a retrospective Italian study of 68,000 percutaneous liver biopsies in which all six patients who died did so from intraperitoneal haemorrhage. Three of these patients had had a laparotomy, and all had either cirrhosis or malignant disease, both of which are risk factors for bleeding.".
Halfon P, Munteanu M, Poynard T (2008). "FibroTest-ActiTest as a non-invasive marker of liver fibrosis". Gastroenterol Clin Biol32 (6): 22–39. doi:10.1016/S0399-8320(08)73991-5. பப்மெட்:18973844.
Roguin A (2006). "Rene Theophile Hyacinthe Laënnec (1781-1826): the man behind the stethoscope". Clinical medicine & research4 (3): 230–5. பப்மெட்:17048358.
Grant, A; Neuberger J (1999). "Guidelines on the use of liver biopsy in clinical practice". Gut45 (Suppl 4): 1–11. doi:10.1136/gut.45.2008.iv1. பப்மெட்:10485854. http://gut.bmj.com/cgi/content/full/45/suppl_4/IV1. "The main cause of mortality after percutaneous liver biopsy is intraperitoneal haemorrhage as shown in a retrospective Italian study of 68,000 percutaneous liver biopsies in which all six patients who died did so from intraperitoneal haemorrhage. Three of these patients had had a laparotomy, and all had either cirrhosis or malignant disease, both of which are risk factors for bleeding.".
Halfon P, Munteanu M, Poynard T (2008). "FibroTest-ActiTest as a non-invasive marker of liver fibrosis". Gastroenterol Clin Biol32 (6): 22–39. doi:10.1016/S0399-8320(08)73991-5. பப்மெட்:18973844.
Cosby RL, Yee B, Schrier RW (1989). "New classification with prognostic value in cirrhotic patients". Mineral and electrolyte metabolism15 (5): 261–6. பப்மெட்:2682175.
Anderson RN, Smith BL (2003). "Deaths: leading causes for 2001". National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System52 (9): 1–85. பப்மெட்:14626726.
